Clinical Trials on Keloid Scar in Germany

Total 402 results

St. Elisabethen Krankenhaus Frankfurt GmbH

Recruiting

Low Level Laser Therapy for Better Wound Healing

Surgical Scar Tissue of Cesarean Section or Vaginal Tear or Episiotomy

Germany
Martin-Luther-Universität Halle-Wittenberg

Completed

Preoperative and Intraoperative Sonographic Assessment of Lower Uterine Segment Thickness at Term in Women With Previous Cesarean Delivery - a Ultrasound Method Comparison Study (SALUTARY)

Scar; Previous Cesarean Section

Germany
University Hospital Schleswig-Holstein

Completed

Evaluation of the Product Properties of Individualized 3D-compression Garments to Treat Scars

Burn Scar

Germany
Martin-Luther-Universität Halle-Wittenberg

Completed

Assessing the Stability of Uterine Scar Tissue in Women With Previous History of Caesarean Section Using Multimodal Analyses of the Lower Uterine Segment Including Quantitative Sonography (QUANTUSLUS)

Scar; Previous Cesarean Section

Germany
University Hospital Schleswig-Holstein

Completed

Cutaneous Microcirculation After Plasma Therapy

Burn Scar | Chronic Wound | Burn Injury | Acute Wound

Germany
University Hospital Schleswig-Holstein

Completed

Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy

Burn Scar | Chronic Wound | Burn Injury | Acute Wound | Flap Disorder

Germany
Martin-Luther-Universität Halle-Wittenberg
Otto-von-Guericke University Magdeburg

Completed

Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section (OPSTAR)

Scar; Previous Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence

Germany
University of Ulm

Completed

Pressure Device in the Treatment of Ear Keloids (PRESSURE)

Keloid Ear

Germany
Merz Pharmaceuticals GmbH

Completed

Effectiveness and Safety Study of Overnight Intensive Patch in Scars

Post Dermatological Surgery Scars

Germany
medac GmbH

Completed

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia

Germany
Goethe University

Completed

Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)

AML

Germany
Ludwig-Maximilians - University of Munich

Recruiting

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML (AARON)

Acute Myeloid Leukemia

Germany
Ludwig-Maximilians - University of Munich

Completed

DC Vaccination for Postremission Therapy in AML

Acute Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Completed

Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Germany
University of Ulm

Terminated

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

Acute Myeloid Leukemia

Germany
University Hospital Muenster
Novartis

Completed

Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML)

Acute Myeloid Leukemia

Germany
University Hospital Muenster
Boehringer Ingelheim

Unknown

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Terminated

Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission

Acute Myeloid Leukemia

Germany
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
iOMEDICO AG

Recruiting

Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC (CONFIDHENCE)

Acute Myeloid Leukemia (AML)

Germany
University of Leipzig

Completed

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a (AML2004)

Acute Myeloid Leukaemia

Germany
Technische Universität Dresden

Completed

AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients

Leukemia, Nonlymphoblastic, Acute

Germany
Philogen S.p.A.

Terminated

A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia, Relapsed, Adult

Germany
University Hospital Carl Gustav Carus

Unknown

Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Allogeneic Transplantation

Germany
University of Leipzig

Unknown

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a (OSHO#061)

Acute Myeloid Leukaemia

Germany
Technische Universität Dresden

Completed

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years

Leukemia, Nonlymphocytic, Acute

Germany
Technical University of Munich

Completed

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Germany
University Hospital Muenster
German Federal Ministry of Education and Research; Deutsche Krebshilfe e.V....

Completed

Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)

Acute Myeloid Leukemia

Germany
Hannover Medical School

Recruiting

Venetoclax Registry (VENreg)

Acute Myeloid Leukemia

Germany
Technische Universität Dresden

Completed

PET-CT in AML for Detection of Extramedullary AML Manifestations (PETAML)

Newly Diagnosed or Relapsed Acute Myeloid Leukemia

Germany
University of Freiburg

Completed

Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia, Adult

Germany
University of Freiburg

Completed

Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment

Acute Myeloid Leukemia, in Relapse

Germany
University Hospital Heidelberg
National Center for Tumor Diseases, Heidelberg

Completed

TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib (TEAM)

Acute Myeloid Leukemia

Germany
Dr. Petra Tschanter
BioLineRx, Ltd.

Unknown

BL-8040 Addition to Consolidation Therapy in AML Patients (BLAST)

Acute Myeloid Leukemia

Germany
4SC AG

Completed

Single Dose Study With 4SC-203 in Healthy Volunteers

Acute Myeloid Leukemia

Germany
University Hospital Heidelberg

Terminated

Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) (GnG)

Acute Myeloid Leukemia

Germany
Bone Therapeutics S.A

Completed

A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones (mRUSTUS)

Bone Fracture | Validation Studies | Fracture Healing | X-Ray | Delayed Union Fracture | CT-scan

Germany
Klinikum Nürnberg
University Medicine Greifswald; University Hospital Heidelberg; Technische Universität... and other collaborators

Terminated

Observational Trial of a Therapeutic Platelet Transfusion Regimen

Acute Myeloid Leukemia | Thrombocytopenia

Germany
Technische Universität Dresden
German Research Foundation

Terminated

Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML (HINKL)

Acute Myeloid Leukemia

Germany
Philogen S.p.A.
Boehringer Ingelheim

Completed

Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (PHIBI)

Acute Myeloid Leukemia (AML) Relapse

Germany
University Hospital Muenster
Charite University, Berlin, Germany; Hannover Medical School; University Hospital... and other collaborators

Terminated

Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

Acute Myeloid Leukemia

Germany
University Hospital Muenster
Deutsche Krebshilfe e.V., Bonn (Germany)

Unknown

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Myeloid Leukemia

Germany
University Hospital Regensburg
Celgene; Anticancer Fund, Belgium

Terminated

Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML (AML-ViVA)

Acute Myeloid Leukemia

Germany
Technische Universität Dresden

Completed

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

Myeloid Leukemia

Germany
University of Hamburg-Eppendorf

Active, not recruiting

Clinical Cohort Study - INTERCATH

Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Coronary Syndrome | SCAD

Germany
Johann Wolfgang Goethe University Hospital

Unknown

Efficacy of G-CSF-Priming in Elderly AML Patients

Acute Myeloid Leukemia

Germany
University of Jena

Active, not recruiting

Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose (Ponderosa)

Chronic Myeloid Leukemia, Chronic Phase

Germany
Basilea Pharmaceutica

Completed

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Acute Myeloid Leukemia

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Acute Myeloid Leukemia

Germany
Basilea Pharmaceutica
The Clinical Trials Centre Cologne

Completed

Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia

Acute Myeloid Leukemia

Germany

Clinical Trials on Keloid Scar in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations